首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤血管生成抑制剂的研究进展
引用本文:张丽,徐文方. 肿瘤血管生成抑制剂的研究进展[J]. 中国新药与临床杂志, 2005, 24(3): 242-244
作者姓名:张丽  徐文方
作者单位:山东大学药学院,山东,济南,250012
摘    要:肿瘤生长转移具有血管依赖性,肿瘤血管生成抑制剂能破坏或抑制血管生成,有效的阻止肿瘤生长、转移和复发,是近年来肿瘤研究的新热点之一,也是肿瘤防治的一条新途径。本文对肿瘤血管生成抑制剂的种类、作用机制及临床研究的新进展做一综述。

关 键 词:肿瘤  血管生成抑制剂  基质金属蛋白酶
文章编号:1007-7669(2005)03-0242-03

Study in progress of tumor angiogenesis inhibitors
ZHANG Li,XU Wen-fang. Study in progress of tumor angiogenesis inhibitors[J]. Chinese Journal of New Drugs and Clinical Remedies, 2005, 24(3): 242-244
Authors:ZHANG Li  XU Wen-fang
Abstract:The growth and metastasis of tumor depend on the formation of a vascular network and the angiogenesis.Tumor angiogenesis inhibitor can destory or inhibit tumor neovascularization, effectively block the growth, metastasis and recurrence of cancer, which has been lately become the hotbed in the tumor research. It has also been a new approach for the tumor prevention and cure. The kinds, mechanisms and new clinical research progress of the most potent and promising antiangiogenic agents are reviewed in the paper.
Keywords:neoplasms  angiogenesis inhibitors  matrix metalloproteinases
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号